Home
About
Overview
Sharing Data
ORCID
Help
History (7)
Clinical and Molecular Features of KRAS-Mutated Lung Cancer Patients Treated with Immune Checkpoint Inhibitors.
Diagnosis and management of typical and atypical lung carcinoids.
Increasing clinician participation in tobacco cessation by an implementation science-based tobacco cessation champion program.
Nutritive Sweeteners
Capecitabine and Celecoxib as a Promising Therapy for Thymic Neoplasms.
See All 7 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Capecitabine and Celecoxib as a Promising Therapy for Thymic Neoplasms.
Capecitabine and Celecoxib as a Promising Therapy for Thymic Neoplasms. Am J Clin Oncol. 2018 10; 41(10):963-966.
View in:
PubMed
subject areas
Aged
Antineoplastic Combined Chemotherapy Protocols
Capecitabine
Celecoxib
Female
Follow-Up Studies
Humans
Male
Maximum Tolerated Dose
Middle Aged
Neoplasm Recurrence, Local
Prognosis
Survival Rate
Thymus Neoplasms
authors with profiles
Ravi Salgia